Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
This triple-action way helps the receptor agonist retatrutide be different from semaglutide and tirzepatide
Things they had given up on, activities they assumed were permanently behind them, suddenly become possible again
Retatrutide is an investigational triple agonist peptide (GIP, GLP-1, and glucagon receptor) currently under clinical development for the management of obesity and type 2 diabetes
Our new, ultimate guide compares them head-to-head, giving you clear winners for every major lab test
Semaglutides are a weekly injection that patients can do in the comfort of their own home
Check appearance and dates, and toss pens that are damaged or expired
